Hologic Coverage - MedCity News

Google Cloud unveils medical imaging suite with Hologic, Hackensack Meridian as 1st customers

Katie Adams — Tue, 04 Oct 2022 20:46:50 +0000

Google Cloud unveiled a new product suite to make medical imaging data more interoperable and useful via artificial intelligence. Hackensack Meridian Health has begun using it to detect metastasis in prostate cancer patients earlier, and Hologic is using it to strengthen its diagnostic platform that screens women for cervical cancer.

The post Google Cloud unveils medical imaging suite with Hologic, Hackensack Meridian as 1st customers appeared first on MedCity News.

Hologic makes a multiplex molecular testing move with $795M Mobidiag acquisition

Frank Vinluan — Thu, 08 Apr 2021 16:41:12 +0000

Mobidiag offers multiplex testing, which is the ability to test for multiple pathogens from a single test sample. Hologic said the acquisition will enable the company to enter the acute care test market, which is projected to grow in a post-pandemic world.

The post Hologic makes a multiplex molecular testing move with $795M Mobidiag acquisition appeared first on MedCity News.

FDA grants Hologic, LabCorp Covid-19 diagnostic EUAs, gives states greater leeway for testing

Alaric DeArment — Tue, 17 Mar 2020 18:19:21 +0000

The EUAs follow the ones the agency gave last week to Roche and Thermo Fisher Scientific. The agency is also allowing states to take greater responsibility for authorizing tests for the SARS-CoV-2 virus.

The post FDA grants Hologic, LabCorp Covid-19 diagnostic EUAs, gives states greater leeway for testing appeared first on MedCity News.

A million-dollar marketing juggernaut pushes 3D mammograms

Kaiser Health News — Wed, 23 Oct 2019 19:19:37 +0000

Medical device companies, hospitals, doctors and some patient advocates have put their marketing muscle and millions of dollars behind 3D mammograms, even though the U.S. Preventive Services Task Force hasn’t found it to be more effective than traditional mammograms.

The post A million-dollar marketing juggernaut pushes 3D mammograms appeared first on MedCity News.

Morning Read: J&J ordered to pay $72M to family after woman dies from using talcum powder

Nicole Oran — Wed, 24 Feb 2016 12:55:25 +0000

Also, Hologic said that a study of women screened for breast cancer over multiple years using its Genius 3D mammography system showed a significant drop in recalls.

The post Morning Read: J&J ordered to pay $72M to family after woman dies from using talcum powder appeared first on MedCity News.

Women’s health company Hologic sees stocks jump after patent decision

MassDevice Staff — Sun, 27 Feb 2011 15:20:45 +0000

Medical device company Hologic will continue with a patent infringement case. The original lawsuit alleged that SenoRx violated Hologic’s patents for its MammoSite brachytherapy balloon catheter device. The system delivers radiation to the cavity left from the removal of cancerous breast tissue during lumpectomy.

The post Women’s health company Hologic sees stocks jump after patent decision appeared first on MedCity News.

Early stage biotechs face funding gap as VCs seek surer bets, stronger returns

Frank Vinluan — Tue, 22 Feb 2011 14:21:24 +0000

Early stage biotech companies looking for venture capital have always found it hard to get VC funding, but it looks like it’s only going to get harder. A panel of VCs at the CED Biotech/Life Science conference in Raleigh, North Carolina said that VCs want for surer investments likely to make a strong market impact.

The post Early stage biotechs face funding gap as VCs seek surer bets, stronger returns appeared first on MedCity News.

FDA approves Selenia 3-D mammography tool

MassDevice Staff — Sun, 13 Feb 2011 14:11:53 +0000

A new innovative medical device from Hologic for performing mammograms was approved by the U.S. Food and Drug Administration. The Selenia FDA approval means physicians will have access to “unique and innovative 3-D technology that could significantly enhance existing diagnosis and treatment approaches,” Center for Devices & Radiological Health chief Dr. Jeffrey Shuren stated.

The post FDA approves Selenia 3-D mammography tool appeared first on MedCity News.

Hologic to distribute Angiotech breast biopsy device

MassDevice Staff — Wed, 01 Dec 2010 16:54:26 +0000

A new private-label deal will see Hologic Inc. distributing a soft tissue biopsy instrument manufactured by Angiotech Pharmaceuticals Inc. Angiotech Pharmaceuticals Inc. (NSDQ:ANPI) inked a three-year, private-label deal with Bedford, Mass.-based Hologic Inc. (NSDQ:HOLX). Under the terms of the agreement, Vancouver-based Angiotech will supply Hologic with its soft tissue biopsy device for breast biopsies. The […]

The post Hologic to distribute Angiotech breast biopsy device appeared first on MedCity News.

Hologic’s 3D breast exam system close to FDA approval

MassDevice Staff — Tue, 23 Nov 2010 22:48:23 +0000

Hologic Inc.’s (NASDAQ:HOLX) long wait to launch its 3D breast exam system is close to over. The company received an “approvable letter” from the Food & Drug Administration for its Selenia Dimensions 3-D digital mammography tomosynthesis system. The letter indicates that the final approval of the device maker’s pre-market approval application for the breast exam […]

The post Hologic’s 3D breast exam system close to FDA approval appeared first on MedCity News.

3D mammography system inches toward FDA approval

MassDevice Staff — Mon, 27 Sep 2010 17:18:01 +0000

Hologic Inc.’s (NASDAQ:HOLX) Selenia Dimensions 3D digital mammography tomosynthesis system edged closer to approval from the Food & Drug Administration last week.

The post 3D mammography system inches toward FDA approval appeared first on MedCity News.

Hologic acquires Sentinelle Medical for $85 million

MassDevice Staff — Tue, 06 Jul 2010 23:29:28 +0000

Hologic Inc. (NSDQ:HOLX) agreed to acquire Sentinelle Medical Inc. for $85 million plus contingencies. The deal calls for Bedford, Mass.-based Hologic to pay a “two-year contingent earn out,” according to a press release, for Toronto-based Sentinelle, which makes MRI breast coils, tables and visualization software. The earn-out involves cash payments equal to a multiple of […]

The post Hologic acquires Sentinelle Medical for $85 million appeared first on MedCity News.

C.R. Bard acquires SenoRx for $200 million

MassDevice Staff — Tue, 06 Jul 2010 20:11:10 +0000

C.R. Bard Inc. acquires SenoRx Inc. for $200 million, or $11 per share. C.R. Bard Inc. (NYSE:BCR) closed its acquisition of SenoRx Inc. (NSDQ:SENO). The Murray Hill, N.J.-based device conglomerate bought Irvine, Calif.-based SenoRx for about $200 million, or $11 per share. C.R. Bard made the purchase at a 14 percent premium over SenoRx’s May […]

The post C.R. Bard acquires SenoRx for $200 million appeared first on MedCity News.

Ethicon Endo-Surgery, Hologic settle patent infringement claims by selling each other’s devices

Mary Vanac — Mon, 22 Feb 2010 21:27:07 +0000

Ethicon Endo-Surgery Inc. and a subsidiary of Hologic Inc. have settled their patent infringement disagreements with a $12.5 million payment to Ethicon and the promise to share royalties from selling each other’s breast cancer biopsy devices.

The post Ethicon Endo-Surgery, Hologic settle patent infringement claims by selling each other’s devices appeared first on MedCity News.